Intravenous immunoglobulin (IVIg) treatment can help you fight off infections if you have a weakened immune system or other diseases. Some people may have IVIg instead of other medications (such ...

The FDA cleared an investigational new drug application for a phase 2 trial of GRF312 ophthalmic solution, an immunoglobulin ...

NICE reversed its earlier decision on sparsentan for treating primary immunoglobulin A nephropathy after additional evidence ...

The Food and Drug Administration (FDA) has accepted for Priority Review the Biologics License Application (BLA) for sibeprenlimab for the treatment of immunoglobulin A nephropathy (IgAN) in adults.

Due to the autoimmune etiology of this disorder, IV immunoglobulin (IVIg) or plasma exchange (PE) are the first-line treatments in addition to management of ventilatory failure. IVIg is more ...

"Nuvig Therapeutics begins dosing in trial of NVG-2089 for CIDP" was originally created and published by Clinical Trials Arena, a GlobalData owned brand. The information on this s ...

Selagine, Inc., a spin-out company from the University of Illinois Chicago (UIC), announced today that the U.S. Food and Drug ...

The following is a summary of “Predicting intrathecal immunoglobulin synthesis in the ICU: a comparative study of IgG-based ...

Atrasentan reduced urine protein-to-creatinine ratio by 38% compared with 3% for placebo at week 36. The Food and Drug Administration (FDA) has granted accelerated approval to Vanrafia ...

The relationship between gut microbiota, immunoglobulin A, and vaccine efficacy Date: March 13, 2025 Source: IMIM (Hospital del Mar Medical Research Institute) Summary: A study has established the ...

The mean immunoglobulin decline was 77% at 12 weeks. Most adults with uncontrolled Graves' disease responded favorably to once-weekly batoclimab in a phase 2a trial. Image: Adobe Stock During the ...

The Food and Drug Administration (FDA) has accepted for Priority Review the Biologics License Application (BLA) for sibeprenlimab for the treatment of immunoglobulin A nephropathy (IgAN ...